For example, significant levels of expression of p38α and p38δ have been reported in the primary tumors of most cancers, while p38β and p38γ have significantly decreased expression in the primary tumors of breast cancer, lung adenocarcinoma, and glioblastoma multiforme [9]. This evidence concerns the gene MAPK11 and breast carcinoma.